Events & Training for November 2015

Meningitis and Septicaemia in Children and Adults Conference 2015

04 November 2015 - 05 November 2015

Meningitis Research Foundation’s 10th international conference will take place in London on 4 and 5 November 2015 at the Royal Society of Medicine, London. The conference will bring together internationally renowned experts from the UK and around the world to address the most important issues of the day. Consistently attracting over 250 delegates from a range of specialties and international institutions, this conference is a key event in the calendar for many of the world’s leading authorities in infectious disease, paediatrics, vaccinology, public health and tropical medicine. The two days of oral presentations, debates and poster presentations provide a showcase for talent and cutting edge research, as well as an opportunity to network and share opinions.

Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE London UK

World Vaccine Congress Europe 2015

09 November 2015 - 11 November 2015

urope’s most successful vaccine event is now entering its 16th year. For 15 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception. From humble beginnings as a small conference with a handful of exhibition stands, in 2014 we had 65 sessions, over 75 speakers and 29 sponsors. The agenda was built to reflect the new activities in the vaccine industry. From a focus to what is going on in the cancer or influenza vaccine fields to parallel tracks on discovery and pre-clinical validation, clinical trials and manufacturing methods there was something for the full range of people who work to get a vaccine to market. For 2015 we are going to be building on previous success by making sure that the agenda delves into what is truly innovative in the sector right now and the speakers are true disrupters and trend-setters.

Silken Puerta América, Madrid

Advances in Cell Based Assays

10 November 2015 - 11 November 2015

SMi Group are thrilled to present the 8th annual conference in the industry leading series, Advances in Cell Based Assays, taking place on 10th & 11th November 2015 in Central London, UK. Due to improvements in detection technology and sensitivity in drug screening, recent reports predict the cell based assays market to reach $4.7 billion in 2016. With a fresh new agenda for 2015, Advances in Cell Based Assays arrives at the perfect time to expand scientific horizons in key topics such as drug toxicity testing, live imaging, 3D modelling, phenotype screening, formulation in assay development, plus much more! We have worked closely with a leading panel of experts such as AstraZeneca, GSK, Pfizer and Johnson & Johnson, to create a packed programme that has been tailored for an audience of professionals working in regenerative medicine using 3D cell based assays and high-throughput technologies.

Holiday Inn Kensington Forum, London, UK

4th Cancer Epigenetics Conference

16 November 2015 - 17 November 2015

Lately the field of epigenetics has been rapidly changing and progressing. Advances that were made possible because of the Human Genome Project have opened up new possibilities about how epigenetics can be used to stop cancer. Scientists have recently discovered that there are potentially two sets of enzymes that are responsible for regulating the chemical structure of chromatin, which consists of the methyl and acetyl marks in the chromatin structure. Theoretically, by changing and controlling the chromatin structure, scientists can attempt to gain epigenetic control of DNA in order to potentially stop aberrant gene expression. Interest in applying and translating epigenetic science to cancer therapy is growing at an exponential pace.We invite you to join us as colleagues from industry and academia gather to discuss the latest research for therapeutics, drug discovery developments, biomarkers, and epigenetic mechanisms in cancer.

Hotel Kabuki, San Francisco, CA, USA

Biosimilars and Biobetters USA

16 November 2015 - 17 November 2015

The US biosimilars market is expected to reach $2 billion by 2018 and with the first biosimilar approved recently in America, this is an exciting time for the biosimilar field with approval in the US expected to increase during the next ten years. The regulatory landscape is evolving rapidly so it is important to understand the developments in the biosimilar guideline framework and the cohesion in legislation between the US and Europe. The learning objectives in the US should be to fully understand the product lifecycle and all aspects of biosimilar research and development.

Renaissance Woodbridge Hotel, Iselin, New Jersey, USA

4th Oncology Partnering & Deal-Making Conference

16 November 2015 - 17 November 2015

We invite you to attend the 4th Oncology Partnering & Deal-Making Conference, which will take place November 16-17, 2015 in San Francisco, CA. This event is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry. Experts in the field of oncology will present on the latest discoveries, novel technologies, business development trends, markets, innovative partnering for value creation, and landscape of Immuno-oncology. There will be a mix of presentations and interactive panel discussions so join your business development colleagues at this unique partnering forum!

Hotel Kabuki, San Francisco, CA, USA

Biotech and Money New York 2015

17 November 2015

Biotech and Money New York aims to provide genuine peer 2 peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncover new ideas to move the industry forward. At its heart is a mission to promote NYC and the region as a center for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital. The congress is a catalyst for dialogue, debate and deal making to help lead growth in life science and healthcare investment and the building of billion dollar businesses. The congress will help forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in in the industry. The congress will help promote NYC as a center for life sciences, and provide a physical platform and forum for advancing translation and connecting innovative life science companies with capital and partnership opportunities.

TKP New York Conference Center, New York, USA